Myriad Genetics, Inc. (NASDAQ:MYGN) received analyst consensus rating of “Hold”
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has earned a consensus rating of “Hold” from five ratings firms, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages … Read more